||Researchers from the University
of Pennsylvania School of Medicine have found that a
widely practiced, stress-reducing meditation technique can
significantly reduce the severity of congestive heart failure.
||Researchers evaluated 23 African American
men and women, average age 64, who were recently hospitalized
with New York Heart Association class II or III congestive heart
failure. Participants were randomized to either the Transcendental
Meditation® (TM) technique
or health education – in addition to standard medical treatment.
||According to the study authors, TM most likely improves heart
failure by reducing sympathetic nervous system activation associated
with stress that is known to contribute to the failing heart.
||The study appears in the Winter 2007 issue
of Ethnicity & Disease.
In this high-tech age of modern medicine, could it be possible
to treat the leading cause of death in the U.S. through the power
? According to a first-of-its-kind randomized
study conducted by researchers from the University
of Pennsylvania School of Medicine,
a widely practiced,
stress-reducing meditation technique can significantly reduce the
severity of congestive
. The study appears in the
Winter 2007 issue of Ethnicity & Disease.
results of this study indicate that transcendental meditation can
be effective in improving the functional capacity and quality of
life of congestive heart failure patients” said Ravishankar
Jayadevappa, PhD, lead author and Research Assistant
Professor in Penn’s Division
of Geriatric Medicine. “These
results also suggest long-term improvements in survival in these
Jayadevappa and fellow researchers from Penn
evaluated 23 African American men and women, average age 64, who
were recently hospitalized with New York Heart Association class
II or III congestive heart failure. Participants were randomized
to either the Transcendental Meditation® (TM) technique or
health education – in addition to standard medical treatment.
measured changes in heart function with a six-minute walk test,
and measures for quality of life, depression, and re-hospitalizations.
Changes in outcomes from baseline to three and six months after
treatment were analyzed.
to Jayadevappa, the TM group significantly improved on the six-minute
walk test after both three and six months of TM practice compared
to the control group. The TM group also showed improvement in quality
of life measurements, depression, and had fewer re-hospitalizations.
present finding is consistent with previous research demonstrating
that TM reduces factors that contribute to the cause or progression
of heart failure, such a high
blood pressure, stress, metabolic
ventricular hypertrophy (enlargement of the heart)
and severity of atherosclerosis (hardening
of the arteries). Further validation of the outcomes of this study
is planned via a large, multi-center trial with long-term follow-up.
According to the study authors, TM most likely improves heart
failure by reducing sympathetic
nervous system activation associated
with stress that is known to contribute to the failing heart.
study was sponsored by the National
Institutes of Health-National
Center for Complementary and Alternative Medicine, in a collaboration
between the University of Pennsylvania with
the Institute for Natural Medicine
and Prevention at Maharishi
University of Management.
PENN Medicine is a $2.9 billion enterprise
dedicated to the related missions of medical education, biomedical
research, and high-quality patient care. PENN Medicine consists
of the University of Pennsylvania School of Medicine (founded in
1765 as the nation's first medical school) and the University of
Pennsylvania Health System.
Penn's School of Medicine is ranked #2 in the nation for receipt
of NIH research funds; and ranked #3 in the nation in U.S. News
& World Report's most recent ranking of top research-oriented
medical schools. Supporting 1,400 fulltime faculty and 700 students,
the School of Medicine is recognized worldwide for its superior
education and training of the next generation of physician-scientists
and leaders of academic medicine.
The University of Pennsylvania Health System includes three hospitals,
all of which have received numerous national patient-care honors [Hospital
of the University of Pennsylvania; Pennsylvania Hospital, the nation's
first hospital; and Penn Presbyterian Medical Center]; a faculty practice
plan; a primary-care provider network; two multispecialty satellite
facilities; and home care and hospice.
Penn Medicine is one of the world’s leading academic medical centers, dedicated to the related missions of medical education, biomedical research, and excellence in patient care. Penn Medicine consists of the Raymond and Ruth Perelman School of Medicine at the University of Pennsylvania (founded in 1765 as the nation's first medical school) and the University of Pennsylvania Health System, which together form a $7.8 billion enterprise.
The Perelman School of Medicine has been ranked among the top medical schools in the United States for more than 20 years, according to U.S. News & World Report’s survey of research-oriented medical schools. The School is consistently among the nation’s top recipients of funding from the National Institutes of Health, with $405 million awarded in the 2017 fiscal year.
The University of Pennsylvania Health System’s patient care facilities include: The Hospital of the University of Pennsylvania and Penn Presbyterian Medical Center — which are recognized as one of the nation’s top “Honor Roll” hospitals by U.S. News & World Report — Chester County Hospital; Lancaster General Health; Penn Medicine Princeton Health; Penn Wissahickon Hospice; and Pennsylvania Hospital – the nation’s first hospital, founded in 1751. Additional affiliated inpatient care facilities and services throughout the Philadelphia region include Good Shepherd Penn Partners, a partnership between Good Shepherd Rehabilitation Network and Penn Medicine, and Princeton House Behavioral Health, a leading provider of highly skilled and compassionate behavioral healthcare.
Penn Medicine is committed to improving lives and health through a variety of community-based programs and activities. In fiscal year 2017, Penn Medicine provided $500 million to benefit our community.